FDA Adverse Event Injury Summary report: N

CONTIGEN BARD COLLAGEN IMPLANT TREATMENT SYRINGE

MDR report key: 4212956 · Received October 24, 2014

Report

Report Number
1018233-2014-00289
Event Type
Injury
Date Received
October 24, 2014
Report Date
October 2, 2014
Manufacturer
C.R. BARD, INC. (COVINGTON)
Product Code
LNM
PMA / PMN Number
P900030
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE LOT NUMBER IS UNK; THEREFORE, THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED IN THE PT'S MEDICAL RECORDS THAT AS A RESULT OF HAVING THE PRODUCT IMPLANTED, THE PT HAS EXPERIENCED URINARY STRESS INCONTINENCE AND INTRINSIC SPHINCTER DEFICIENCY WHICH REQUIRED ADDITIONAL SURGICAL INTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
678052 CONTIGEN BARD COLLAGEN IMPLANT TREATMENT SYRINGE LNM C.R. BARD, INC. (COVINGTON) NA UNK

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention